Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
7.24M
-
Shares change
-
-14.3K
-
Total reported value, excl. options
-
$19.1M
-
Value change
-
+$25.9K
-
Number of buys
-
13
-
Number of sells
-
-15
-
Price
-
$2.64
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2025
51 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q3 2025.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.24M shares
of 41M outstanding shares and own 17.64% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (3.17M shares), Murchinson Ltd. (1.75M shares), BOOTHBAY FUND MANAGEMENT, LLC (845K shares), Rathbones Group PLC (233K shares), BANK OF AMERICA CORP /DE/ (150K shares), RENAISSANCE TECHNOLOGIES LLC (149K shares), DIMENSIONAL FUND ADVISORS LP (147K shares), WELLS FARGO & COMPANY/MN (130K shares), CITADEL ADVISORS LLC (112K shares), and BlackRock, Inc. (110K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.